Loading...
Can we use epigenetics to prime chemoresistant lymphomas?
Chemoresistance remains a challenging clinical problem in the treatment of many lymphoma patients. Epigenetic derangements have been implicated in both intrinsic and acquired chemoresistance. Mutations in epigenetic processes shift entire networks of signaling pathways. They influence tumor suppress...
Na minha lista:
| Udgivet i: | Hematology Am Soc Hematol Educ Program |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Hematology
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7727522/ https://ncbi.nlm.nih.gov/pubmed/33275728 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/hematology.2020000092 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|